GB0418414D0 - Peptide - Google Patents

Peptide

Info

Publication number
GB0418414D0
GB0418414D0 GBGB0418414.9A GB0418414A GB0418414D0 GB 0418414 D0 GB0418414 D0 GB 0418414D0 GB 0418414 A GB0418414 A GB 0418414A GB 0418414 D0 GB0418414 D0 GB 0418414D0
Authority
GB
United Kingdom
Prior art keywords
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0418414.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NovaBiotics Ltd
Original Assignee
Rowett Research Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowett Research Services Ltd filed Critical Rowett Research Services Ltd
Priority to GBGB0418414.9A priority Critical patent/GB0418414D0/en
Publication of GB0418414D0 publication Critical patent/GB0418414D0/en
Priority to UAA200701921A priority patent/UA96564C2/en
Priority to NZ553494A priority patent/NZ553494A/en
Priority to DK08001112.5T priority patent/DK1927597T3/en
Priority to CN2013101617432A priority patent/CN103360485A/en
Priority to PT05778505T priority patent/PT1778720E/en
Priority to PL05778505T priority patent/PL1778720T3/en
Priority to EP05778505A priority patent/EP1778720B1/en
Priority to CN2005800281216A priority patent/CN101031583B/en
Priority to DE602005023315T priority patent/DE602005023315D1/en
Priority to ES05778505T priority patent/ES2351879T3/en
Priority to SG10201606278UA priority patent/SG10201606278UA/en
Priority to MX2007002057A priority patent/MX2007002057A/en
Priority to ES08001112.5T priority patent/ES2613027T3/en
Priority to BRPI0514420-5A priority patent/BRPI0514420B1/en
Priority to PCT/GB2005/003245 priority patent/WO2006018652A2/en
Priority to JP2007526571A priority patent/JP5020078B2/en
Priority to AU2005273638A priority patent/AU2005273638B2/en
Priority to SI200531161T priority patent/SI1778720T1/en
Priority to DK05778505.7T priority patent/DK1778720T3/en
Priority to KR1020077003571A priority patent/KR101234780B1/en
Priority to SG200905379-4A priority patent/SG155211A1/en
Priority to EP08001112.5A priority patent/EP1927597B1/en
Priority to SG2013007356A priority patent/SG188092A1/en
Priority to PT80011125T priority patent/PT1927597T/en
Priority to RU2007109518/04A priority patent/RU2396273C2/en
Priority to EP09005438A priority patent/EP2096118A1/en
Priority to CA2974538A priority patent/CA2974538A1/en
Priority to AT05778505T priority patent/ATE479704T1/en
Priority to CA2575058A priority patent/CA2575058C/en
Priority to CN2013101618914A priority patent/CN103360486A/en
Priority to NZ584340A priority patent/NZ584340A/en
Priority to US11/573,770 priority patent/US7847059B2/en
Priority to EP16179810.3A priority patent/EP3147293B1/en
Priority to EP16176481.6A priority patent/EP3141559A1/en
Priority to IL180727A priority patent/IL180727A/en
Priority to ZA200701394A priority patent/ZA200701394B/en
Priority to GB0703060A priority patent/GB2431404A/en
Priority to NO20071369A priority patent/NO342832B1/en
Priority to HK07110561.1A priority patent/HK1105982A1/en
Priority to US12/893,663 priority patent/US8088888B2/en
Priority to CY20101101093T priority patent/CY1113684T1/en
Priority to IL213319A priority patent/IL213319A/en
Priority to US13/170,975 priority patent/US8350003B2/en
Priority to US13/308,479 priority patent/US8470769B2/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0418414.9A 2004-08-18 2004-08-18 Peptide Ceased GB0418414D0 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GBGB0418414.9A GB0418414D0 (en) 2004-08-18 2004-08-18 Peptide
NZ553494A NZ553494A (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
EP08001112.5A EP1927597B1 (en) 2004-08-18 2005-08-18 Antibacterial peptides
PT80011125T PT1927597T (en) 2004-08-18 2005-08-18 Antibacterial peptides
DK08001112.5T DK1927597T3 (en) 2004-08-18 2005-08-18 ANTIBACTERIAL PEPTIDES
SG2013007356A SG188092A1 (en) 2004-08-18 2005-08-18 Peptide
PT05778505T PT1778720E (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
PL05778505T PL1778720T3 (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
EP05778505A EP1778720B1 (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
CN2005800281216A CN101031583B (en) 2004-08-18 2005-08-18 Antimicrobial peptides containing arginine and/or lysine motif
DE602005023315T DE602005023315D1 (en) 2004-08-18 2005-08-18 ANTIMICROBIAL PEPTIDES WITH AN ARGININ AND / OR LYSIN-SUBJECT MOTIVE
ES05778505T ES2351879T3 (en) 2004-08-18 2005-08-18 COMPREHENSIVE ANTIMICROBIAL PEPTIDES OF A REASON CONTAINING ARGININE AND / OR LISINE.
SG10201606278UA SG10201606278UA (en) 2004-08-18 2005-08-18 Peptide
MX2007002057A MX2007002057A (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif.
ES08001112.5T ES2613027T3 (en) 2004-08-18 2005-08-18 Antibacterial peptides
BRPI0514420-5A BRPI0514420B1 (en) 2004-08-18 2005-08-18 Peptide, or a pharmaceutically acceptable salt thereof, and, use of a peptide
PCT/GB2005/003245 WO2006018652A2 (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
JP2007526571A JP5020078B2 (en) 2004-08-18 2005-08-18 peptide
AU2005273638A AU2005273638B2 (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
RU2007109518/04A RU2396273C2 (en) 2004-08-18 2005-08-18 Antimicrobial peptides containing arginine- and lysine-containing motive
DK05778505.7T DK1778720T3 (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine and / or lysine-containing motif
KR1020077003571A KR101234780B1 (en) 2004-08-18 2005-08-18 Peptide
SG200905379-4A SG155211A1 (en) 2004-08-18 2005-08-18 Peptide
UAA200701921A UA96564C2 (en) 2004-08-18 2005-08-18 Peptide
CN2013101617432A CN103360485A (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine-and/or lysine-containing motif
EP16176481.6A EP3141559A1 (en) 2004-08-18 2005-08-18 Antimicrobial peptides
SI200531161T SI1778720T1 (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
EP09005438A EP2096118A1 (en) 2004-08-18 2005-08-18 Antifungal peptides
CA2974538A CA2974538A1 (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine-and/or lysine-containing motif
AT05778505T ATE479704T1 (en) 2004-08-18 2005-08-18 ANTIMICROBIAL PEPTIDES WITH A MOTIF CONTAINING ARGININE AND/OR LYSINE
CA2575058A CA2575058C (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine-and/or lysine-containing motif
CN2013101618914A CN103360486A (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising arginine-and/or lysine-containing motif
NZ584340A NZ584340A (en) 2004-08-18 2005-08-18 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
US11/573,770 US7847059B2 (en) 2004-08-18 2005-08-18 Methods for treatment of a dermatophytic fungal infection
EP16179810.3A EP3147293B1 (en) 2004-08-18 2005-08-18 Antimicrobial peptides
IL180727A IL180727A (en) 2004-08-18 2007-01-16 Anti-fungal peptides comprising an arginine- and/or lysine-containing motif
ZA200701394A ZA200701394B (en) 2004-08-18 2007-02-16 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
GB0703060A GB2431404A (en) 2004-08-18 2007-02-19 Peptide
NO20071369A NO342832B1 (en) 2004-08-18 2007-03-14 Use of antimicrobial peptides comprising arginine for the treatment of fungal infections.
HK07110561.1A HK1105982A1 (en) 2004-08-18 2007-09-28 Antimicrobial peptides comprising an arginine-and/or lysine-containing motif
US12/893,663 US8088888B2 (en) 2004-08-18 2010-09-29 Method of treatment of a fungal infection with poly arginine peptides
CY20101101093T CY1113684T1 (en) 2004-08-18 2010-11-30 ANTI-MICROBIAKA CONTAINERS CONTAINING AN ARGININE - KAI / OR LYSINE - CONTAINING A MOBILE
IL213319A IL213319A (en) 2004-08-18 2011-06-02 Polylysine peptides for use in the treatment of bacterial infections
US13/170,975 US8350003B2 (en) 2004-08-18 2011-06-28 Method of treatment of non-dermatophytic fungal infections
US13/308,479 US8470769B2 (en) 2004-08-18 2011-11-30 Method of treatment of bacterial infection by administration of poly-lysine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0418414.9A GB0418414D0 (en) 2004-08-18 2004-08-18 Peptide

Publications (1)

Publication Number Publication Date
GB0418414D0 true GB0418414D0 (en) 2004-09-22

Family

ID=33042253

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0418414.9A Ceased GB0418414D0 (en) 2004-08-18 2004-08-18 Peptide

Country Status (4)

Country Link
ES (1) ES2351879T3 (en)
GB (1) GB0418414D0 (en)
UA (1) UA96564C2 (en)
ZA (1) ZA200701394B (en)

Also Published As

Publication number Publication date
UA96564C2 (en) 2011-11-25
ES2351879T3 (en) 2011-02-11
ZA200701394B (en) 2008-10-29

Similar Documents

Publication Publication Date Title
GB0508863D0 (en) Peptide
EP1735335A4 (en) Cell-killing peptide
ZA200700895B (en) Polypeptide
GB0516527D0 (en) Peptides
GB0417887D0 (en) Protein
GB0415196D0 (en) Polypeptide
GB0402904D0 (en) Polypeptide
GB0418414D0 (en) Peptide
GB0423128D0 (en) Peptides
GB0425033D0 (en) Peptides
GB0401882D0 (en) Protein
GB0416035D0 (en) Protein
GB0509835D0 (en) Peptide
GB0516303D0 (en) Peptide
GB0400606D0 (en) Polypeptide
GB0400605D0 (en) Polypeptide
GB0405512D0 (en) Protein
GB0422058D0 (en) Protein
GB0400087D0 (en) Protein
GB0403142D0 (en) Protein
GB0403742D0 (en) Protein
GB0403979D0 (en) Protein
GB0404929D0 (en) Protein
GB0402088D0 (en) Protein
GB0405644D0 (en) Protein

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: NOVABIOTICS LIMITED

Free format text: FORMER APPLICANT(S): ROWETT RESEARCH SERVICES LIMITED

AT Applications terminated before publication under section 16(1)